Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 53 min ago

Vertex Pushes Oral Drug into Phase III Kidney Disease Trial, Eyes Accelerated Approval

Sun, 02/04/2024 - 02:00
Vertex Pushes Oral Drug into Phase III Kidney Disease Trial, Eyes Accelerated Approval 4/2/2024

Roivant Posts Phase II Eye Disease Win for TYK2 Drug, Plans Pivotal Program

Sun, 02/04/2024 - 02:00
Roivant Posts Phase II Eye Disease Win for TYK2 Drug, Plans Pivotal Program 4/2/2024

Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win

Sun, 02/04/2024 - 02:00
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win 4/2/2024

Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year

Sun, 02/04/2024 - 02:00
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year 4/2/2024

Gritstone Fails Cancer Vaccine Trial, Plans Phase III and Public Offering

Sun, 02/04/2024 - 02:00
Gritstone Fails Cancer Vaccine Trial, Plans Phase III and Public Offering 4/2/2024

AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise

Thu, 01/04/2024 - 02:00
AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise 4/1/2024

Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s

Thu, 01/04/2024 - 02:00
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s 4/1/2024

BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati

Thu, 01/04/2024 - 02:00
BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati 4/1/2024

Lack of Medicare Coverage for GLP-1 Drugs Tied to Lower Prescription Rates: Study

Thu, 01/04/2024 - 02:00
Lack of Medicare Coverage for GLP-1 Drugs Tied to Lower Prescription Rates: Study 4/1/2024

Fractyl Secures FDA Approval for Weight Maintenance Study After Discontinuation of GLP-1s

Thu, 01/04/2024 - 02:00
Fractyl Secures FDA Approval for Weight Maintenance Study After Discontinuation of GLP-1s 4/1/2024

Will Oral Weight-Loss Drugs Break Open an Already Lucrative Market?

Thu, 01/04/2024 - 02:00
Will Oral Weight-Loss Drugs Break Open an Already Lucrative Market? 4/1/2024

Psychosis: The Other Big Alzheimer’s Therapeutic Target

Thu, 01/04/2024 - 02:00
Psychosis: The Other Big Alzheimer’s Therapeutic Target 4/1/2024

6 Recently Approved Cell & Gene Therapies—And Why They Matter

Thu, 01/04/2024 - 02:00
6 Recently Approved Cell & Gene Therapies—And Why They Matter 4/1/2024

FDA Action Alert: Vanda, Basilea and J&J/Legend

Thu, 01/04/2024 - 02:00
FDA Action Alert: Vanda, Basilea and J&J/Legend 4/1/2024